AMGN

NASDAQ HEALTHCARE

Amgen Inc

$380.49

-$7.15 (-1.84%)

Live quote

52w: $269.77 – $398.00

Loading chart…

P/E Ratio27.13

P/B Ratio22.77

EV/EBITDA—

Debt/Equity—

ROE83.91%

ROIC—

Revenue Growth9.95%

Gross Margin—

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.

Own AMGN? Track it here.

Create a free account to add AMGN to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account